Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Combinatorial Chemistry & High Throughput Screening
  4. Volume 28, Issue 1
  5. Article
Volume 28, Issue 1
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Endometrial carcinoma (EC) is a common malignancy worldwide. Existing evidence has revealed that EC could be associated with abnormal gene expression. Meantime, evidence supports that miRNAs act as critical regulators in gene expression through the binding to the 3’-untranslated region (3’-UTR). Accordingly, this review concludes some recent studies focusing on miRNAs that influence EC, aiming at understanding the association between miRNAs and EC more clearly and providing a reference for further studies on miRNA-related drugs treating EC.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073299444240308145725
2024-03-19
2025-01-19

  • From This Site

    /content/journals/cchts/10.2174/0113862073299444240308145725
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. TorreL.A. BrayF. SiegelR.L. FerlayJ. Lortet-TieulentJ. JemalA. Global cancer statistics, 2012.CA Cancer J. Clin.20156528710810.3322/caac.21262 25651787
     [Google Scholar]
  2. BrayF. FerlayJ. SoerjomataramI. SiegelR.L. TorreL.A. JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.201868639442410.3322/caac.21492 30207593
     [Google Scholar]
  3. YenT.T. MiyamotoT. AsakaS. ChuiM.H. WangY. LinS.F. StoneR.L. FaderA.N. AsakaR. KashimaH. ShiozawaT. WangT.L. ShihI.M. TannerE.J. III Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma.Gynecol. Oncol.2018150342643110.1016/j.ygyno.2018.06.025 30126589
     [Google Scholar]
  4. LevineD.A. SchultzN. CherniackA.D. AkbaniR. LiuY. ShenH. RobertsonA.G. PashtanI. ShenR. BenzC.C. YauC. LairdP.W. DingL. ZhangW. MillsG.B. KucherlapatiR. MardisE.R. LevineD.A. Integrated genomic characterization of endometrial carcinoma.Nature20134977447677310.1038/nature12113 23636398
     [Google Scholar]
  5. HaripriyaV.B.H.A. BaghelA. Prognostic factors implicated in endometric cancer patients: A hospital based study. J. Advan. Med. Dental Sci.Res.20186123841
     [Google Scholar]
  6. ParkJ.Y. NamJ.H. Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer.Oncologist201520327027810.1634/theoncologist.2013‑0445 25673106
     [Google Scholar]
  7. YangB. XuY. ZhuQ. XieL. ShanW. NingC. XieB. ShiY. LuoX. ZhangH. ChenX. Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer.Gynecol. Oncol.20191531556210.1016/j.ygyno.2019.01.014 30674421
     [Google Scholar]
  8. YangH.C. LiuJ.C. LiuF.S. Fertility-preserving treatment of stage IA, well-differentiated endometrial carcinoma in young women with hysteroscopic resection and high-dose progesterone therapy.Taiwan. J. Obstet. Gynecol.2019581909310.1016/j.tjog.2018.11.017 30638488
     [Google Scholar]
  9. LuT.X. RothenbergM.E. MicroRNA.J. Allergy Clin. Immunol.201814141202120710.1016/j.jaci.2017.08.034 29074454
     [Google Scholar]
  10. XuY.Y. TianJ. HaoQ. YinL.R. MicroRNA-495 downregulates FOXC1 expression to suppress cell growth and migration in endometrial cancer.Tumour Biol.201637123925110.1007/s13277‑015‑3686‑6 26198045
     [Google Scholar]
  11. BaranwalS. AlahariS.K. miRNA control of tumor cell invasion and metastasis.Int. J. Cancer201012661283129010.1002/ijc.25014 19877123
     [Google Scholar]
  12. KumarswamyR. VolkmannI. ThumT. Regulation and function of miRNA-21 in health and disease.RNA Biol.20118570671310.4161/rna.8.5.16154 21712654
     [Google Scholar]
  13. AssaliA. AkhavanO. AdeliM. RazzazanS. DinarvandR. ZanganehS. SoleimaniM. DinarvandM. AtyabiF. Multifunctional core-shell nanoplatforms (gold@graphene oxide) with mediated NIR thermal therapy to promote miRNA delivery.Nanomedicine20181461891190310.1016/j.nano.2018.05.016 29885900
     [Google Scholar]
  14. CatalanottoC. CogoniC. ZardoG. MicroRNA in control of gene expression: An overview of nuclear functions.Int. J. Mol. Sci.20161710171210.3390/ijms17101712 27754357
     [Google Scholar]
  15. AssaliA. AkhavanO. MottaghitalabF. AdeliM. DinarvandR. RazzazanS. ArefianE. SoleimaniM. AtyabiF. Cationic graphene oxide nanoplatform mediates miR-101 delivery to promote apoptosis by regulating autophagy and stress.Int. J. Nanomedicine2018135865588610.2147/IJN.S162647 30319254
     [Google Scholar]
  16. LiQ. QiuX.M. LiQ.H. WangX.Y. LiL. XuM. DongM. XiaoY.B. MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7.Oncol. Rep.20153352354236010.3892/or.2015.3812 25708247
     [Google Scholar]
  17. O’BrienJ. HayderH. ZayedY. PengC. Overview of microRNA biogenesis, mechanisms of actions, and circulation.Front. Endocrinol.2018940210.3389/fendo.2018.00402 30123182
     [Google Scholar]
  18. KonnoY. DongP. XiongY. SuzukiF. LuJ. CaiM. WatariH. MitamuraT. HosakaM. HanleyS.J.B. KudoM. SakuragiN. MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells.Oncotarget20145156049606210.18632/oncotarget.2157 25153722
     [Google Scholar]
  19. YeW. XueJ. ZhangQ. LiF. ZhangW. ChenH. HuangY. ZhengF. MiR-449a functions as a tumor suppressor in endometrial cancer by targeting CDC25A.Oncol. Rep.20143231193119910.3892/or.2014.3303 24993091
     [Google Scholar]
  20. MozosA. CatasúsL. D’AngeloE. SerranoE. EspinosaI. FerrerI. PonsC. PratJ. The FOXO1-miR27 tandem regulates myometrial invasion in endometrioid endometrial adenocarcinoma.Hum. Pathol.201445594295110.1016/j.humpath.2013.12.007 24746199
     [Google Scholar]
  21. ZhangG. HouX. LiY. ZhaoM. MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer ishikawa cells.BMC Cancer201414144010.1186/1471‑2407‑14‑440 24929707
     [Google Scholar]
  22. LvY. ChenS. WuJ. LinR. ZhouL. ChenG. ChenH. KeY. Upregulation of long non-coding RNA OGFRP1 facilitates endometrial cancer by regulating miR-124-3p/SIRT1 axis and by activating PI3K/AKT/GSK-3β pathway.Artif. Cells Nanomed. Biotechnol.20194712083209010.1080/21691401.2019.1617727 31131636
     [Google Scholar]
  23. JiangT. SuiD. YouD. YaoS. ZhangL. WangY. ZhaoJ. ZhangY. RETRACTED ARTICLE: MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.Cell Cycle201817101268127810.1080/15384101.2018.1475829 29888640
     [Google Scholar]
  24. PanX. LiD. HuoJ. KongF. YangH. MaX. LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis.Cell Death Dis.20189330310.1038/s41419‑018‑0291‑9 29467441
     [Google Scholar]
  25. MaJ. LiD. KongF.F. YangD. YangH. MaX.X. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.J. Exper. Clini. Can. Res. CR201837119
     [Google Scholar]
  26. ShuS. LiuX. XuM. GaoX. ChenS. ZhangL. LiR. MicroRNA-320a acts as a tumor suppressor in endometrial carcinoma by targeting IGF-1R.Int. J. Mol. Med.20194331505151210.3892/ijmm.2019.4051 30628637
     [Google Scholar]
  27. YanH. SunB.M. ZhangY.Y. LiY.J. HuangC.X. FengF.Z. LiC. Upregulation of miR-183-5p is responsible for the promotion of apoptosis and inhibition of the epithelial-mesenchymal transition, proliferation, invasion and migration of human endometrial cancer cells by downregulating Ezrin.Int. J. Mol. Med.20184252469248010.3892/ijmm.2018.3853 30226564
     [Google Scholar]
  28. DongP. XiongY. YueJ. XuD. IhiraK. KonnoY. KobayashiN. TodoY. WatariH. Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes.J. Exp. Clin. Cancer Res.201938129510.1186/s13046‑019‑1306‑9 31287002
     [Google Scholar]
  29. ZhangW. ChenJ.H. ShanT. Aguilera-BarrantesI. WangL.S. HuangT.H.M. RaderJ.S. ShengX. HuangY.W. miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation.Lab. Invest.201898111397140710.1038/s41374‑018‑0092‑x 29955087
     [Google Scholar]
  30. XieW. QinW. KangY. ZhouZ. QinA. MicroRNA-340 inhibits tumor cell proliferation and induces apoptosis in endometrial carcinoma cell line RL 95-2.Med. Sci. Monit.2016221540154610.12659/MSM.898121 27153225
     [Google Scholar]
  31. TuC. WangF. WanJ. MicroRNA-381 inhibits cell proliferation and invasion in endometrial carcinoma by targeting the IGF-1R.Mol. Med. Rep.201817340904098 29257334
     [Google Scholar]
  32. ZhangC. WangB. WuL. MicroRNA 409 may function as a tumor suppressor in endometrial carcinoma cells by targeting Smad2.Mol. Med. Rep.2019191622628 30431090
     [Google Scholar]
  33. LuK. LinJ. JiangJ. Osthole inhibited cell proliferation and induced cell apoptosis through decreasing CPEB2 expression via up-regulating miR-424 in endometrial carcinoma.J. Recept. Signal Transduct. Res.2020401899610.1080/10799893.2019.1710846 31971049
     [Google Scholar]
  34. LiuY. ChenS. ZongZ.H. GuanX. ZhaoY. CircRNA WHSC1 targets the miR‐646/NPM1 pathway to promote the development of endometrial cancer.J. Cell. Mol. Med.202024126898690710.1111/jcmm.15346 32378344
     [Google Scholar]
  35. CaiL. ChenJ.J. DengF.M. WangL. ChenY. MiR‐326 regulates the proliferation and apoptosis of endometrial cancer by targeting Bcl‐2.J. Obstet. Gynaecol. Res.202147262163010.1111/jog.14572 33210403
     [Google Scholar]
  36. GuoJ. YeF. XieW. ZhangX. ZengR. ShengW. MiY. ShengX. The HOXC‐AS2/miR‐876‐5p/HKDC1 axis regulates endometrial cancer progression in a high glucose‐related tumor microenvironment.Cancer Sci.202211372297231010.1111/cas.15384 35485648
     [Google Scholar]
  37. ChenL. ShenM. LncRNA VPS9D1-AS1 sponging miR-520a-5p contributes to the development of uterine corpus endometrial carcinoma by enhancing BIRC5 expression.Mol. Biotechnol.202264121328133910.1007/s12033‑022‑00510‑3 35619019
     [Google Scholar]
  38. MaJ. ZhaoX. ShiL. Circ 003390/Eukaryotic translation initiation factor 4A3 promoted cell migration and proliferation in endometrial cancer via vascular endothelial growth factor signaling by miR-195-5p.Bioengineered2022135119581197210.1080/21655979.2022.2069358 35546509
     [Google Scholar]
  39. ShiR. ZhangW. ZhangJ. YuZ. AnL. ZhaoR. ZhouX. WangZ. WeiS. WangH. CircESRP1 enhances metastasis and epithelial–mesenchymal transition in endometrial cancer via the miR-874-3p/CPEB4 axis.J. Transl. Med.202220113910.1186/s12967‑022‑03334‑6 35317822
     [Google Scholar]
  40. LiangH. LiuY. FuL. LiL. GongN. Berberine inhibits the development of endometrial cancer through circ_ZNF608/miR-377-3p/COX2 axis.Autoimmunity202255748549510.1080/08916934.2021.2010050 35876160
     [Google Scholar]
  41. XuC. ZhaiJ. FuY. Overexpression of nuclear enriched autosomal transcript 1 facilitates cell proliferation, migration invasion, and suppresses apoptosis in endometrial cancer by targeting MicroRNA-202-3p/T cell immunoglobulin and mucin domain 4 axis.Cancer Biother. Radiopharm.202237981582310.1089/cbr.2020.3902 32882142
     [Google Scholar]
  42. LiJ. ZhangZ. HuY. WeiQ. ShaoX. Circ_0039569 contributes to the paclitaxel resistance of endometrial cancer via targeting miR-1271-5p/PHF6 pathway.Anticancer Drugs202233988389210.1097/CAD.0000000000001377 36136988
     [Google Scholar]
  43. LeiT.X. HeD.J. CaoJ. LvW.G. CircWDR26 regulates endometrial carcinoma progression via miR-212-3p-mediated typing genes MSH2.Eur. J. Med. Res.202227113510.1186/s40001‑022‑00755‑3 35897048
     [Google Scholar]
  44. ZhouY. PanA. ZhangY. LiX. Hsa_circ_0039569 facilitates the progression of endometrial carcinoma by targeting the miR-197/high mobility group protein A1 axis.Bioengineered20221324212422510.1080/21655979.2022.2027060 35130798
     [Google Scholar]
  45. LiuY. YuanS. LiuX. HuangY. QiuP. GaoJ. DengG. LncRNA GATA3-AS1 promoted invasion and migration in human endo-metrial carcinoma by regulating the miR-361/ARRB2 axis.J. Mol. Med.202210091271128610.1007/s00109‑022‑02222‑2 35788718
     [Google Scholar]
  46. LiuY. YuanH. HeT. Downregulated circular RNA hsa_circ_0005797 inhibits endometrial cancer by modulating microRNA-298/Catenin delta 1 signaling.Bioengineered20221334634464510.1080/21655979.2021.2013113 34852711
     [Google Scholar]
  47. ZhongY. WangY. DangH. WuX. LncRNA AFAP1-AS1 contributes to the progression of endometrial carcinoma by regulating miR-545-3p/VEGFA pathway.Mol. Cell. Probes20205310160610.1016/j.mcp.2020.101606 32504788
     [Google Scholar]
  48. WangY. MaH. LiY. SuR. MiR-192-5p-modified tumor-associated macrophages-derived exosome suppressed endometrial cancer progression through targeting IRAK1/NF-κB signaling.Reprod. Sci.202229243644710.1007/s43032‑021‑00789‑8 35000146
     [Google Scholar]
  49. PengT.F. ZhouY.J. ZhouJ. ZhouY. LiX.C. OuyangQ. Long non‐coding RNA VPS9D1‐AS1 enhances proliferation, invasion, and epithelial‐mesenchymal transition in endometrial cancer via MIR ‐377‐3p/SGK1.Kaohsiung J. Med. Sci.202238111048105910.1002/kjm2.12606 36245426
     [Google Scholar]
  50. LaiT. QiuH. SiL. ZhenY. ChuD. GuoR. Long noncoding RNA BMPR1B-AS1 facilitates endometrial cancer cell proliferation and metastasis by sponging miR-7-2-3p to modulate the DCLK1/Akt/NF-κB pathway.Cell Cycle202221151599161810.1080/15384101.2022.2060003 35404759
     [Google Scholar]
  51. ShuL. PengY. ZhongL. FengX. QiaoL. YiY. CircZNF124 regulates cell proliferation, leucine uptake, migration and invasion by miR‐199b‐5p/SLC7A5 pathway in endometrial cancer.Immun. Inflamm. Dis.2021941291130510.1002/iid3.477 34145797
     [Google Scholar]
  52. WangB. LuY. FengE. hsa_circ_0001610 knockdown modulates miR‐646‐STAT3 axis to suppress endometrial carcinoma progression.J. Gene Med.2021236e333710.1002/jgm.3337 33822442
     [Google Scholar]
  53. FanJ.T. ZhouZ.Y. LuoY.L. LuoQ. ChenS.B. ZhaoJ.C. ChenQ.R. Exosomal lncRNA NEAT1 from cancer-associated fibro-blasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway.Neoplasia202123769270310.1016/j.neo.2021.05.004 34153644
     [Google Scholar]
  54. HuJ. PengX. DuW. HuangY. ZhangC. ZhangX. circSLC6A6 Sponges miR-497-5p to promote endometrial cancer progression via the PI4KB/hedgehog axis.J. Immunol. Res.2021202111310.1155/2021/5512391 34258297
     [Google Scholar]
  55. XingY. SunX. LiF. JiangX. JiangA. LiX. LvR. ShaoL. Long non-coding RNA (lncRNA) HOXB-AS3 promotes cell proliferation and inhibits apoptosis by regulating ADAM9 expression through targeting miR-498-5p in endometrial carcinoma.J. Int. Med. Res.202149610.1177/03000605211013548 34187214
     [Google Scholar]
  56. ZhouW.J. ZhangJ. XieF. WuJ.N. YeJ.F. WangJ. WuK. LiM.Q. CD45RO - CD8 + T cell-derived exosomes restrict estrogen-driven endometrial cancer development via the ERβ/miR-765/PLP2/Notch axis.Theranostics202111115330534510.7150/thno.58337 33859750
     [Google Scholar]
  57. XiongH. WangN. ChenH. ZhangM. LinQ. MicroRNA 199a/b 5p inhibits endometrial cancer cell metastasis and invasion by tar-geting FAM83B in the epithelial to mesenchymal transition signaling pathway.Mol. Med. Rep.202123530410.3892/mmr.2021.11943 33649801
     [Google Scholar]
  58. LiaoL. ChenY. ZhouJ. YeJ. MicroRNA-133b inhibits ntumor cell proliferation, migration and invasion by targeting SUMO1 in endometrial carcinoma.Technol. Cancer Res. Treat.20212010.1177/15330338211065241 34918563
     [Google Scholar]
  59. LiangM. ChenH. MinJ. miR-379-5p inhibits proliferation and invasion of the endometrial cancer cells by inhibiting expression of ROR1.Acta Biochim. Pol.202168465966510.18388/abp.2020_5538 34115460
     [Google Scholar]
  60. HeY. XuS. QiY. TianJ. XuF. Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression.J. Ovarian Res.202114116310.1186/s13048‑021‑00906‑w 34789312
     [Google Scholar]
  61. JiangY. QiaoZ. JiangJ. ZhangJ. LINC00958 promotes endometrial cancer cell proliferation and metastasis by regulating the miR‐145‐3p/TCF4 axis.J. Gene Med.2021237e334510.1002/jgm.3345 33885186
     [Google Scholar]
  62. GengA. LuoL. RenF. ZhangL. ZhouH. GaoX. miR-29a-3p inhibits endometrial cancer cell proliferation, migration and invasion by targeting VEGFA/CD C42/PAK1.BMC Cancer202121184310.1186/s12885‑021‑08506‑z 34289832
     [Google Scholar]
  63. YuJ. FanQ. LiL. The MCM3AP-AS1/miR-126/VEGF axis regulates cancer cell invasion and migration in endometrioid carcinoma.World J. Surg. Oncol.202119121310.1186/s12957‑021‑02316‑0 34256796
     [Google Scholar]
  64. NiJ. TianW. LiangS. WangH. RenY. Promoter methylation-mediated silencing of the MiR-192-5p promotes endometrial cancer progression by targeting ALX1.Int. J. Med. Sci.202118122510252010.7150/ijms.58954 34104082
     [Google Scholar]
  65. MenY. ZhangL. AiH. MicroRNA-145-5p over-expression suppresses proliferation, migration and invasion and promotes apoptosis of human endometrial cancer cells by targeting dual specific phosphatase 6.J. South. Med. Uni.20204016166
     [Google Scholar]
  66. WuB. RenA. TianY. HuangR. Hsa_circ_0075960 Serves as a Sponge for miR-361-3p/SH2B1 in Endometrial Carcinoma.Technol. Cancer Res. Treat.20201910.1177/1533033820983079 33356989
     [Google Scholar]
  67. ZhangH.H. LiR. LiY.J. YuX.X. SunQ.N. LiA.Y. KongY. eIF4E related miR 320a and miR 340 5p inhibit endometrial carcinoma cell metastatic capability by preventing TGF β1 induced epithelial mesenchymal transition.Oncol. Rep.2020432447460 31894279
     [Google Scholar]
  68. GuZ.R. LiuW. The LncRNA AL161431.1 targets miR-1252-5p and facilitates cellular proliferation and migration via MAPK signaling in endometrial carcinoma.Eur. Rev. Med. Pharmacol. Sci.202024522942302 32196580
     [Google Scholar]
  69. ZhengY. YangX. WangC. ZhangS. WangZ. LiM. WangY. WangX. YangX. HDAC6, modulated by miR-206, promotes endometrial cancer progression through the PTEN/AKT/mTOR pathway.Sci. Rep.2020101357610.1038/s41598‑020‑60271‑4 32107418
     [Google Scholar]
  70. LiuY. ChangY. CaiY. Hsa_circ_0061140 promotes endometrial carcinoma progression via regulating miR-149-5p/STAT3.Gene202074514462510.1016/j.gene.2020.144625 32224273
     [Google Scholar]
  71. LiuD. QiuM. JiangL. LiuK. RETRACTED: Long noncoding RNA HOXB-AS1 is upregulated in endometrial carcinoma and sponged miR-149-3p to upregulate Wnt10b.Technol. Cancer Res. Treat.20201910.1177/1533033820967462 33073693
     [Google Scholar]
  72. CaiP. WuM. ZhangB. WuS. WeiH. WeiL. Long non coding RNA SNHG12 regulates cell proliferation, invasion and migration in endometrial cancer by targeting miR 4429.Mol. Med. Rep.20202242842285010.3892/mmr.2020.11370 32945395
     [Google Scholar]
  73. LiuY. ChangY. CaiY. Circ_0067835 sponges miR‐324‐5p to induce HMGA1 expression in endometrial carcinoma cells.J. Cell. Mol. Med.20202423139271393710.1111/jcmm.15996 33169939
     [Google Scholar]
  74. ShiY. ZhaJ. ZuoM. YanQ. SongH. Long noncoding RNA CHL1‐AS1 promotes cell proliferation and migration by sponging miR‐6076 to regulate CHL1 expression in endometrial cancer.J. Cell. Biochem.202012132655266310.1002/jcb.29486 31736153
     [Google Scholar]
  75. WangG.F. WenL.N. LncRNA SNHG14 promotes proliferation of endometrial cancer through regulating microRNA-655-3p.Eur. Rev. Med. Pharmacol. Sci.202024201041010418 33155197
     [Google Scholar]
  76. YangY. WuJ. ZhouH. LiuW. WangJ. ZhangQ. RETRACTED ARTICLE: STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A.Cell Cycle202019121502151610.1080/15384101.2020.1757936 32401659
     [Google Scholar]
  77. LuM. DingN. ZhuangS. LiY. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells.Mol. Cell. Biochem.20204691-291910.1007/s11010‑020‑03723‑9 32314193
     [Google Scholar]
  78. ZongZ.H. LiuY. ChenS. ZhaoY. Circ_PUM1 promotes the development of endometrial cancer by targeting the miR‐136/NOTCH3 pathway.J. Cell. Mol. Med.20202474127413510.1111/jcmm.15069 32073729
     [Google Scholar]
  79. NiJ. LiangS. ShanB. TianW. WangH. RenY. Methylation associated silencing of miR 638 promotes endometrial carcinoma progression by targeting MEF2C.Int. J. Mol. Med.20204561753177010.3892/ijmm.2020.4540 32186750
     [Google Scholar]
  80. LiuY. ChangY. CaiY. Inhibition of Lnc-OC1 induced cell apoptosis and decreased cell viability by releasing mir-34a and inhibiting pd-l1 in endometrial carcinoma.Reprod. Sci.202027101848185610.1007/s43032‑020‑00202‑w 32748220
     [Google Scholar]
  81. ZhaoJ. DongX. TaoS.J. LiuX.L. LiZ. LiuJ.M. ChenY. MDM4 is targeted by miR-449b-5p to promote the proliferation of endometrial carcinoma.Eur. Rev. Med. Pharmacol. Sci.202024221152811535 33275219
     [Google Scholar]
  82. WeiD. TianM. FanW. ZhongX. WangS. ChenY. ZhangS. Circular RNA circ_0000043 promotes endometrial carcinoma pro-gression by regulating miR-1271-5p/CTNND1 axis.Arch. Gynecol. Obstet.202130341075108710.1007/s00404‑020‑05849‑z 33128584
     [Google Scholar]
  83. ChenR. ZhangM. LiuW. ChenH. CaiT. XiongH. ShengX. LiuS. PengJ. WangF. ChenH. LinW. XuX. ZhengW. JiangQ. Estrogen affects the negative feedback loop of PTENP1-miR200c to inhibit PTEN expression in the development of endometrioid endometrial carcinoma.Cell Death Dis.2018101410.1038/s41419‑018‑1207‑4 30584245
     [Google Scholar]
  84. GaoX. CaiY. AnR. miR 215 promotes epithelial to mesenchymal transition and proliferation by regulating LEFTY2 in endometrial cancer.Int. J. Mol. Med.20184231229123610.3892/ijmm.2018.3703 29845221
     [Google Scholar]
  85. ZhuL. WangX. WangT. ZhuW. ZhouX. miR 494 3p promotes the progression of endometrial cancer by regulating the PTEN/PI3K/AKT pathway.Mol. Med. Rep.2019191581588 30431102
     [Google Scholar]
  86. BaoW. ZhangY. LiS. FanQ. QiuM. WangY. LiY. JiX. YangY. SangZ. XuW. YangY. WuS. ZhuY. miR 107 5p promotes tumor proliferation and invasion by targeting estrogen receptor α in endometrial carcinoma.Oncol. Rep.201941315751585 30569100
     [Google Scholar]
  87. YangX. XingG. LiuS. LiB. HeY. WangF. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression.Biomed. Pharmacother.202012510983910.1016/j.biopha.2020.109839
     [Google Scholar]
  88. XinW. GaoX. ZhaoS. ZhaoP. YuH. WuQ. HuaK. LncRNA RP11-395G23.3 suppresses the endometrial cancer progression via regulating microRNA-205-5p/PTEN axis.Am. J. Transl. Res.202012844224433 32913516
     [Google Scholar]
  89. ShenX.C. SunY.Q. YanL. ZhaoX.X. Effect of miR1290 on the growth of endometrial cancer and the related mechanismZhonghua Zhong Liu Za Zhi2022442130138 35184456
     [Google Scholar]
  90. LiX. LiuY. Hsa_circ_0000437 inhibits the development of endometrial carcinoma through miR-626/CDKN1B axis.Protein Pept. Lett.202229761162010.2174/0929866529666220622125016 35733309
     [Google Scholar]
  91. PanY. WangX. LiY. YanP. ZhangH. Human umbilical cord blood mesenchymal stem cells-derived exosomal microRNA-503-3p inhibits progression of human endometrial cancer cells through downregulating MEST.Cancer Gene Ther.2022298-91130113910.1038/s41417‑021‑00416‑3 34997218
     [Google Scholar]
  92. DaiZ. LuoH. ChenJ. LiL. MiR-210-3p accelerates tumor-relevant cell functions of endometrial carcinoma by repressing RUNX1T1.Mutat. Res.202282511179310.1016/j.mrfmmm.2022.111793 35963185
     [Google Scholar]
  93. TianC. SuJ. MaZ. WuY. MaH. lncRNA NBAT1 inhibits cell metastasis and promotes apoptosis in endometrial cancer by sponging miR-21-5p to regulate PTEN.Comput. Math. Methods Med.2022202211010.1155/2022/9304392 35912140
     [Google Scholar]
  94. XiaoY. HuangW. HuangH. WangL. WangM. ZhangT. FangX. XiaX. miR-182-5p and miR-96-5p target PIAS1 and mediate the negative feedback regulatory loop between PIAS1 and STAT3 in endometrial cancer.DNA Cell Biol.202140461862810.1089/dna.2020.6379 33751900
     [Google Scholar]
  95. DongH. LiY. ZhouJ. SongJ. MiR-18a-5p promotes proliferation, migration, and invasion of endometrial cancer cells by targeting THBD.Crit. Rev. Eukaryot. Gene Expr.2021312637310.1615/CritRevEukaryotGeneExpr.2021037776 34347980
     [Google Scholar]
  96. LiuY. CaiX. CaiY. ChangY. lncRNA OIP5-AS1 suppresses cell proliferation and invasion of endometrial cancer by regulating PTEN/AKT via sponging miR-200c-3p.J. Immunol. Res.2021202111610.1155/2021/4861749 34368370
     [Google Scholar]
  97. WangP. ZhaoX. WuX. TangG. YuanL. RETRACTED ARTICLE: MiR-15b-3p promotes the malignant progression of endometrial cancer cells through targeting KLF2.Cell Cycle202120141431144010.1080/15384101.2021.1941611 34224334
     [Google Scholar]
  98. SunX. HouL. QiuC. KongB. MiR-501 promotes tumor proliferation and metastasis by targeting HOXD10 in endometrial cancer.Cell. Mol. Biol. Lett.20212612010.1186/s11658‑021‑00268‑7 34022794
     [Google Scholar]
  99. YangP YunK ZhangR CircRNA circ-ATAD1 is downregulated in endometrial cancer and suppresses cell invasion and migration by downregulating miR-10a through methylation.Retraction in: Mamm Genome202132648849410.1007/s00335‑021‑09899‑9
     [Google Scholar]
  100. WangC. LiQ. HeY. MicroRNA 21 5p promotes epithelial to mesenchymal transition by targeting SRY box 17 in endometrial cancer.Oncol. Rep.20204361897190510.3892/or.2020.7556 32236579
     [Google Scholar]
  101. ZhengW.P. MengF.L. WangL.Y. miR-544a Stimulates endometrial carcinoma growth via targeted inhibition of reversion-inducing cysteine-rich protein with Kazal motifs.Mol. Cell. Probes20205310157210.1016/j.mcp.2020.101572 32525042
     [Google Scholar]
  102. WangQ. YangY. LiangX. RETRACTED ARTICLE: LncRNA CTBP1-AS2 sponges miR-216a to upregulate PTEN and suppress endometrial cancer cell invasion and migration.J. Ovarian Res.20201313710.1186/s13048‑020‑00639‑2 32293505
     [Google Scholar]
  103. DouX.Q. ChenX.J. ZhouQ. WenM.X. ZhangS.Z. ZhangS.Q. miR‐335 modulates Numb alternative splicing via targeting RBM10 in endometrial cancer.Kaohsiung J. Med. Sci.202036317117710.1002/kjm2.12149 31894898
     [Google Scholar]
  104. XiaoL. HeY. PengF. YangJ. YuanC. Endometrial cancer cells promote m2-like macrophage polarization by delivering exosomal mirna-21 under hypoxia condition.J. Immunol. Res.202020201910.1155/2020/9731049 33110923
     [Google Scholar]
  105. YangC. Ota-KurogiN. IkedaK. OkumuraT. Horie-InoueK. TakedaS. InoueS. MicroRNA-191 regulates endometrial cancer cell growth via TET1-mediated epigenetic modulation of APC.J. Biochem.2020168171410.1093/jb/mvaa014 32003827
     [Google Scholar]
  106. XinW. ZhaoS. HanX. ZhaoP. YuH. GaoX. LiP. WuQ. DingJ. HuaK. lncRNA LA16c 313D11.11 modulates the development of endometrial cancer by binding to and inhibiting microRNA 205 5p function and indirectly increasing PTEN activity.Int. J. Oncol.202057135536310.3892/ijo.2020.5046 32319598
     [Google Scholar]
  107. QinX. YanL. ZhaoX. LiC. FuY. microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer.Oncol. Lett.2012461290129610.3892/ol.2012.896 23226804
     [Google Scholar]
  108. DobersteinK. BretzN.P. SchirmerU. FieglH. BlahetaR. BreunigC. Müller-HolznerE. ReimerD. ZeimetA.G. AltevogtP. miR-21-3p is a positive regulator of L1CAM in several human carcinomas.Cancer Lett.2014354245546610.1016/j.canlet.2014.08.020 25149066
     [Google Scholar]
  109. SeligerB. MassaC. Modulation of lymphocyte functions in the microenvironment by tumor oncogenic pathways.Front. Immunol.20221388363910.3389/fimmu.2022.883639 35663987
     [Google Scholar]
  110. DongreA. WeinbergR.A. New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer.Nat. Rev. Mol. Cell Biol.2019202698410.1038/s41580‑018‑0080‑4 30459476
     [Google Scholar]
  111. ZaravinosA. The regulatory role of microRNAs in EMT and cancer.J. Oncol.2015201511310.1155/2015/865816 25883654
     [Google Scholar]
  112. HanC. MoK. JiangL. WangK. TengL. miR-183-5p promotes proliferation, invasion, and glycolysis of thyroid carcinoma cells by targeting FOXO1.Mol. Cell. Biochem.202247741195120610.1007/s11010‑022‑04357‑9 35084673
     [Google Scholar]
  113. HuangC. HuG. Shikonin suppresses proliferation and induces apoptosis in endometrioid endometrial cancer cells via modulating miR-106b/PTEN/AKT/mTOR signaling pathway.Biosci. Rep.2018382BSR2017154610.1042/BSR20171546 29449346
     [Google Scholar]
  114. LiL. ShouH. WangQ. LiuS. Investigation of the potential theranostic role of KDM5B/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma.Gene2019694768210.1016/j.gene.2018.12.076 30658067
     [Google Scholar]
  115. GaoY. QianH. TangX. DuX. WangG. ZhangH. YeF. LiuT. Superparamagnetic iron oxide nanoparticle-mediated expression of miR-326 inhibits human endometrial carcinoma stem cell growth.Int. J. Nanomedicine2019142719273110.2147/IJN.S200480 31114192
     [Google Scholar]
  116. HajipourM.J. RahebJ. AkhavanO. ArjmandS. MashinchianO. RahmanM. AbdolahadM. SerpooshanV. LaurentS. MahmoudiM. Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide.Nanoscale20157198978899410.1039/C5NR00520E 25920546
     [Google Scholar]
  117. AssaliA. RazzazanS. AkhavanO. MottaghitalabF. AdeliM. AtyabiF. The bio-interface between functionalized Au NR@GO nanoplatforms with protein corona and their impact on delivery and release system.Colloids Surf. B Biointerfaces201917389189810.1016/j.colsurfb.2018.10.042 30551306
     [Google Scholar]
  118. GuoJ.L. TangT. LiJ.H. YangY.H. ZhangL. QuanY. LncRNA HEIH enhances paclitaxel-tolerance of endometrial cancer cells via activation of mapk signaling pathway.Pathol. Oncol. Res.20202631757176610.1007/s12253‑019‑00718‑w 31650338
     [Google Scholar]
  119. SiW. ShenJ. ZhengH. FanW. The role and mechanisms of action of microRNAs in cancer drug resistance.Clin. Epigenetics20191112510.1186/s13148‑018‑0587‑8 30744689
     [Google Scholar]
  120. LiL. QuY.W. LiY.P. Over-expression of miR-1271 inhibits endometrial cancer cells proliferation and induces cell apoptosis by targeting CDK1.Eur. Rev. Med. Pharmacol. Sci.2017211228162822 28682437
     [Google Scholar]
  121. LiuX. WangH. ZhuZ. YeY. MaoH. ZhangS. Micro RNA ‐105 targets SOX 9 and inhibits human glioma cell progression.FEBS Lett.2016590234329434210.1002/1873‑3468.12458 27736002
     [Google Scholar]
  122. AhmedE.A. RajendranP. ScherthanH. The microRNA-202 as a diagnostic biomarker and a potential tumor suppressor.Int. J. Mol. Sci.20222311587010.3390/ijms23115870 35682549
     [Google Scholar]
  123. ChenS. SunK.X. LiuB.L. ZongZ.H. ZhaoY. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.Mol. Cancer20161511110.1186/s12943‑016‑0496‑4 26832151
     [Google Scholar]
  124. DevorE.J. MiecznikowskiJ. SchicklingB.M. Gonzalez-BosquetJ. LankesH.A. ThakerP. ArgentaP.A. PearlM.L. ZweizigS.L. MannelR.S. BrownA. RamirezN.C. IoffeO.B. ParkK.J. CreasmanW.T. BirrerM.J. MutchD. LeslieK.K. Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study.Gynecol. Oncol.2017147364865310.1016/j.ygyno.2017.09.025 28969912
     [Google Scholar]
  125. DongP. XiongY. YueJ. J B HanleyS. Kobayashi, N.; Todo, Y.; Watari, H. Exploring lncRNA-mediated regulatory networks in endometrial cancer cells and the tumor microenvironment: Advances and challenges.Cancers201911223410.3390/cancers11020234 30781521
     [Google Scholar]
  126. WangN. GuoY. SongL. TongT. FanX. Circular RNA intraflagellar transport 80 facilitates endometrial cancer progression through modulating miR-545-3p/FAM98A signaling.J. Gynecol. Oncol.2022331e210.3802/jgo.2022.33.e2 34783205
     [Google Scholar]
  127. ZhouY. WangC. MaoL. WangY. XiaL. ZhaoW. ShenJ. ChenJ. Long noncoding RNA HOTAIR mediates the estrogen-induced metastasis of endometrial cancer cells via the miR-646/NPM1 axis.Am. J. Physiol. Cell Physiol.20183146C690C70110.1152/ajpcell.00222.2017 29466670
     [Google Scholar]
  128. JacobyE. BrownJ.B. The future of computational chemogenomics.Methods Mol. Biol.2018182542545010.1007/978‑1‑4939‑8639‑2_15 30334216
     [Google Scholar]
  129. MaghsoudiS. Taghavi ShahrakiB. RamehF. NazarabiM. FatahiY. AkhavanO. RabieeM. MostafaviE. LimaE.C. SaebM.R. RabieeN. A review on computer‐aided chemogenomics and drug repositioning for rational COVID ‐19 drug discovery.Chem. Biol. Drug Des.2022100569972110.1111/cbdd.14136 36002440
     [Google Scholar]
  130. Onen-BayramF.E. DurmazI. SchermanD. HerscoviciJ. Cetin-AtalayR. A novel thiazolidine compound induces caspase-9 dependent apoptosis in cancer cells.Bioorg. Med. Chem.201220175094510210.1016/j.bmc.2012.07.016 22867707
     [Google Scholar]
/content/journals/cchts/10.2174/0113862073299444240308145725
Loading

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Review Article
Keyword(s): 3’-UTR; endometrial carcinoma; miRNA; oncogene; STRTI; tumor suppressor

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test